Therefore, hypermethylation of SEMA3B CpG-islands could be suggested as a progression marker for ccRCC and NSCLC (especially SCC), and for the SEMA3B mRNA level as a marker of metastasis development in lung ADC. The gene discussed is SEMA3B; the disease is nonpapillary renal cell carcinoma.